Medtronic Initiates Landmark Study Of Neurostimulation Therapy For Failed Back Surgery Syndrome

First Patients Treated in Global Clinical Trial Evaluating Impact of Therapy on Predominant Low Back Pain Medtronic, Inc. (NYSE: MDT) have announced the start of PROMISE, a Prospective, Randomized Study of Multicolumn Implantable Lead Stimulation for Predominant Low Back Pain...
Back Pain News From Medical News Today


Related Content